About
Max Freidlin is an organ-preservation and biomedical research professional currently listed as a Senior Research Associate at Until. Public records also place him at Georgia Tech and the National Cancer Institute ecosystem, where he presented and coauthored work on ex vivo perfusion systems and related biomedical engineering topics. His visible profile is that of an early-career researcher rather than a capital allocator.
Areas of interest
organ preservationtransplantation researchbiomedical engineeringtissue engineeringoncology researchbiomaterialsdrug delivery